It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Abstract
Evolutionary annotation of genome maintenance (GM) proteins has conventionally been established by remote relationships within protein sequence databases. However, often no significant relationship can be established. Highly sensitive approaches to attain remote homologies based on iterative profile-to-profile methods have been developed. Still, these methods have not been systematically applied in the evolutionary annotation of GM proteins. Here, by applying profile-to-profile models, we systematically survey the repertoire of GM proteins from bacteria to man. We identify multiple GM protein candidates and annotate domains in numerous established GM proteins, among other PARP, OB-fold, Macro, TUDOR, SAP, BRCT, KU, MYB (SANT), and nuclease domains. We experimentally validate OB-fold and MIS18 (Yippee) domains in SPIDR and FAM72 protein families, respectively. Our results indicate that, surprisingly, despite the immense interest and long-term research efforts, the repertoire of genome stability caretakers is still not fully appreciated.
Here the authors use computational methods for sequence and structure analysis of genome maintenance proteins to catalog and identify genome maintenance families across species. This allows to identify several genome maintenance family members.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Danish Cancer Society, Genome Integrity, Danish Cancer Institute, Copenhagen, Denmark (GRID:grid.417390.8) (ISNI:0000 0001 2175 6024); University of Southern Denmark, Department of Biochemistry and Molecular Biology, Odense M, Denmark (GRID:grid.10825.3e) (ISNI:0000 0001 0728 0170); Karolinska Institute, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Science for Laboratory, Solna, Sweden (GRID:grid.465198.7)
2 University of Southern Denmark, Department of Biochemistry and Molecular Biology, Odense M, Denmark (GRID:grid.10825.3e) (ISNI:0000 0001 0728 0170)
3 Danish Cancer Institute (DCI), Lipidomics Core Facility, Copenhagen, Denmark (GRID:grid.10825.3e)
4 Karolinska Institute, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Science for Laboratory, Solna, Sweden (GRID:grid.465198.7)
5 Danish Cancer Society Research Center, Cancer Structural Biology, Copenhagen, Denmark (GRID:grid.417390.8) (ISNI:0000 0001 2175 6024)
6 Danish Cancer Society Research Center, Cancer Structural Biology, Copenhagen, Denmark (GRID:grid.417390.8) (ISNI:0000 0001 2175 6024); Technical University of Denmark, Cancer Systems Biology, Section for Bioinformatics, Department of Health and Technology, Lyngby, Denmark (GRID:grid.5170.3) (ISNI:0000 0001 2181 8870)
7 Danish Cancer Society, Genome Integrity, Danish Cancer Institute, Copenhagen, Denmark (GRID:grid.417390.8) (ISNI:0000 0001 2175 6024); Karolinska Institute, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Science for Laboratory, Solna, Sweden (GRID:grid.465198.7)